ARI Orthopaedics 2026: advancing dialogue on cartilage and disc repair
The ARI Orthopaedics Conference 2026 (Cartilage & Disc) concluded today in Davos, bringing together an international community of researchers, clinicians, and industry experts. Hosted by the AO Research Institute Davos (ARI) and organised by the ARI’s Sybille Grad and Zhen Li, the three-day meeting reinforced the importance of open, multidisciplinary exchange in addressing some of the most persistent challenges in orthopaedic research.
A central focus of this year’s conference was the repair and regeneration of articular cartilage and intervertebral disc tissue. Despite significant progress in understanding their structure and function, both tissues remain difficult to treat due to their limited intrinsic healing capacity.
The conference opened with the presentation of the Lifetime Achievement Award to Brian Johnstone, acknowledging his contributions to cartilage research and his long-standing relationship with the ARI and its conference. Apart from having been tied to the conference—previously known as eCM conferences—since 2002, Johnstone also chairs the ARI’s Advisory Committee, which provides operational and strategic scientific advice on behalf of the AO Foundation Board.
Across the three days, the programme featured contributions from internationally recognized experts, illustrating the breadth of innovation in the field. Xudong Joshua Li (US) presented on neuroimmune interactions in degenerative disc disease. Martin Englund (Sweden) offered a broader perspective on osteoarthritis, examining the condition through an evolutionary lens, and Rui Yue spoke about progenitor cells in the perichondrium. Further sessions highlighted advances in tissue engineering and biomaterials, with Catherine Le Visage (France) discussing biofabrication approaches to intervertebral disc repair and Julian Jones (UK) presenting developments in biomaterials for cartilage regeneration. Contributions from Chris Little (Australia) and Giuseppe Filardo (Switzerland) addressed joint injury, degeneration, and the challenges of translating cartilage repair strategies into clinical practice.
Throughout the conference, the emphasis on translation—from laboratory research to clinical application—remained a defining feature. ARI Orthopaedics has positioned itself as a forum where clinical needs, experimental research, and technological innovation intersect. Formal sessions were complemented by opportunities for informal exchange, allowing participants to explore potential collaborations and build on discussions initiated during the program. This combination of focused scientific content and structured interaction continues to be a defining characteristic of ARI Orthopaedics and a key driver of its impact.
ARI Director Geoff Richards was keen to point out his team’s effort and excellence: “I would like to thank Carla Escher and Shannon Smit for their tireless administrative work, and of course Sybille Grad and Zhen Li, who put together a highly relevant scientific program. We had a fully sold-out conference with 150 attendees, and we’re proud that the small setting of ARI Orthopaedics continues to give young researchers the opportunity to interact so freely with key opinion leaders in the field.”
As the 2026 conference concludes, the discussions in Davos highlight both the progress made and the challenges that remain in cartilage and disc repair. Advancing these areas of research is critical for improving outcomes in conditions such as osteoarthritis and degenerative disc disease, where effective long-term treatment options are still limited. By bringing together diverse expertise and fostering open exchange, ARI Orthopaedics continues to strenghten the link between scientific discovery and patient care.
